PANDAA qDx™ SARS-CoV-2 is comprised of a single reaction mix containing reagents to amplify and detect targets within the SARS-CoV-2 genome. Two SARS-CoV-2 targets, located in the N gene and RdRp gene, respectively, are amplified by distinct PANDAA primer sets and detected by FAM™-labelled hydrolysis probes. An Internal Control (IC) target is amplified by PANDAA primers and reported using a VIC®-labelled hydrolysis probe.
Safety, legal, quality, & intended use remarks
- This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA)
- This product is covered by one or more patents, trademarks and/or copyrights owned or controlled by Aldatu Biosciences, Inc.